Showing posts with label Quality. Show all posts
Showing posts with label Quality. Show all posts

Wednesday, August 4, 2010

Foreign trained docs are just as good as US docs

Moral of the story: No need to worry if your doctor went to medical school in a different country.  If they did their residency here in the US, they are just as good as us folks who probably paid a heck of a lot more to go to school here in the good old US of A.

Source: AMA Morning Rounds 8/4/2010


Foreign-trained physicians as good as those in the US.

The Los Angeles Times (8/3, Dennis) "Booster Shots" blog reported, "Some US patients -- or even fellow doctors -- might be less than comfortable with a foreign-born physician who didn't graduate from a US medical school." But according to a newly publishedstudy in Health Affairs, "they shouldn't be."
        That assertion is based on an analysis of "244,153 hospitalizations of patients with congestive heart failure or acute heart attack," the Baltimore Sun (8/3, Walker) "Picture of Health" blog reported. Investigators eventually discovered that physicians "trained abroad provide medical care as good as that offered by US-trained physicians." On the other hand, "Americans who trained overseas had higher patient death rates."
        Specifically, the "percentage of in-hospital deaths for congestive heart failure was 3.4% for domestically trained doctors and 3.1% for internationally trained physicians," Modern Healthcare (8/3, Robeznieks) reported. "For foreign-trained doctors who were not US citizens during medical school, the rate death was 3%; for US citizens who trained abroad, it was 3.5%. For heart attack patients, the in-hospital death rate was 13.1% for domestically trained doctors, and 12.7% for those trained abroad."
        The team at the Foundation for Advancement of International Medical Education and Research "offered two possible reasons the Americans who went to foreign medical schools might not perform as well as doctors trained in the United States, or as well as foreign-born doctors," the New York Times (8/3, D7, Grady ) reported. "One is that many of the Americans who study medicine elsewhere do so because their grades and test scores were too low to get into medical school in the United States -- so they may be less capable in the first place. Another possibility is that some of the overseas medical schools Americans attend may not be up to par."
        Bloomberg News (8/3, Wechsler), the Wall Street Journal (8/3, Wang) "Health Blog" and HealthDay (8/3, Goodwin) also covered the study.

Multilayered efficiency system saves Denver health money, jobs. The Denver Post (7/29, Auge) reports that "a multilayered efficiency system known as Lean...has swept through Denver Health over the past five years with the fervor of a religious conversion." And "in an era marked by soaring healthcare costs and epidemic layoffs, even as it serves more and more uninsured patients while public funding dwindles, Denver Health has saved money and jobs -- and improved patient care -- using decades-old Toyota practices" emphasizing cost-cutting and high-quality, consistent work. "Since its Lean conversion in 2005, the city's public health system has benefited to the tune of $54 million in increased revenue, money not spent and expenses cut, according to chief financial officer Peg Burnette."

Moral of the story: Denver is awesome

Source: AMA Morning Rounds 7/29/2010


Multilayered efficiency system saves Denver health money, jobs.

The Denver Post (7/29, Auge) reports that "a multilayered efficiency system known as Lean...has swept through Denver Health over the past five years with the fervor of a religious conversion." And "in an era marked by soaring healthcare costs and epidemic layoffs, even as it serves more and more uninsured patients while public funding dwindles, Denver Health has saved money and jobs -- and improved patient care -- using decades-old Toyota practices" emphasizing cost-cutting and high-quality, consistent work. "Since its Lean conversion in 2005, the city's public health system has benefited to the tune of $54 million in increased revenue, money not spent and expenses cut, according to chief financial officer Peg Burnette."

Friday, April 2, 2010

Treatment checklists may cut hospital deaths

BMJ

(4) Treatment checklists may cut hospital deaths
(Quality Improvement Report: Using care bundles to reduce in-hospital mortality: quantitative survey)
http://www.bmj.com/cgi/content/full/340/mar31_3/c1234
Patient deaths at three London hospitals have been cut by almost 15% after introducing treatment checklists (known as care bundles), finds a study published on bmj.com today.
The researchers say their methods could be used to reduce mortality in many other hospitals.
The North West London Hospitals NHS Trust serves a population of about 500,000 at three sites: Northwick Park Hospital, Central Middlesex Hospital and St Mark's Hospital. In 2005 and 2006, the trust was subject to a series of adverse media stories which impacted on staff morale and also on patients' perceptions of care.
So a group of senior clinicians set out to reduce hospital inpatient mortality and thus increase public confidence in the quality of patient care at the trust.
They developed eight care bundles for 13 diagnostic areas with the highest number of deaths at the trust in 2006-7. These included treatments for stroke, heart failure and chronic obstructive pulmonary disease (COPD).
Care bundles are a collection of treatment checklists based on clinical guidelines that, when combined, improve the effectiveness and safety of patient care.
Adjusted hospital mortality for 2007-8 (the year the care bundles were introduced) was then compared with the previous year using the hospital standardised mortality ratio (HSMR).
The HMSR is a comparative measure of a hospital's overall mortality. It focuses on a group of diagnoses that account for 80% of all hospital deaths nationally and provides a tool for analysing hospital outcomes over time.
The results show that the overall HSMR of the trust fell from 89.6 in 2006-7 to 71.1 in 2007-8, to become the lowest among acute trusts in England.
In 2007-8, 174 fewer deaths occurred in the trust in the targeted diagnoses, and 255 fewer deaths occurred in the HMSR diagnoses compared to 2006-7. This represents a 14.5% decrease in actual deaths from 2006-7 to 2007-8.
This study demonstrates that it is possible to target care bundles across a wide range of diagnoses in a busy acute hospital trust and that this can be associated with a significant reduction in mortality in the targeted diagnostic areas, conclude the authors. These methods could also be generally applicable, they add.
Contacts: Brian Jarman, Emeritus Professor, Imperial College, London, UK
Email b.jarman@imperial.ac.uk

Monday, March 29, 2010

More hospitals offering therapeutic hypothermia for comatose survivors of cardiac arrest

Moral of the story: Hospitals are finally starting to get on the band wagon for offering hypothermic treatment after a heart attack

Source: AMA Morning Rounds 3/29/2010

More hospitals offering therapeutic hypothermia for comatose survivors of cardiac arrest.


USA Today (3/29, Marcus) reports that since the "American Heart Association issued recommendations and guidelines for inducing mild hypothermia in comatose survivors of cardiac arrest" in 2005, the "number of hospitals offering the treatment has climbed." Nearly "500 of about 5,000 hospitals across the country are doing it," and one expert calls therapeutic hypothermia "one of the most exciting and promising interventions for the treatment of cardiac arrest over the past 50 years." Still, "most proponents of cooling say they're surprised that the therapy hasn't caught on faster."

Sunday, March 21, 2010

Aggressive measures to treat cholesterol, hypertension in diabetes not beneficial.

Moral of the story: The guidelines are correct.  Meet the recommended levels and you are good to go (if you have diabetes).

Source: AMA Morning Rounds 3/17/2010


Aggressive measures to treat cholesterol, hypertension in diabetes not beneficial.


The Los Angeles Times (3/15, Maugh) reports that for diabetics, "two new reports from a major nationwide trial called ACCORD released Sunday show that lowering either blood pressure or cholesterol levels below current guidelines do not provide additional benefit and, in fact, increase the risk of side effects." And, "a third arm of the study, released two years ago, shows that lowering blood sugar levels excessively actually increases the risk of heart disease." Despite being disappointing, "the findings 'reduce the cost and potential side effects of drug therapy' and mean that patients will not have to work as hard at reducing blood sugars, lipids, and blood pressure, said Dr. Denise Simons-Morton of the National Heart, Lung and Blood Institute, which funded the trial."

Staples lead to higher risk of infection after joint surgery than traditional stitches

Moral of the story: with JOINT surgery staples are a BAD idea. Ask for traditional stitches (they take longer but decrease your risk of infection)

(1) Staples lead to higher risk of infection after joint surgery than traditional stitches
(Research: Sutures versus staples for skin closure in orthopaedic surgery: meta-analysis)
http://www.bmj.com/cgi/content/full/340/mar16_1/c1199 (Editorial: Staples for skin closure in surgery)
http://www.bmj.com/cgi/content/full/340/mar16_1/c403
Using metal staples to close wounds after orthopaedic (joint) surgery can lead to a greater risk of infection than using traditional nylon sutures, concludes a study published on bmj.com today.
Orthopaedic surgeons are therefore advised to reconsider their use of staples to close wounds after hip or knee surgery while further trials are carried out to confirm these findings.
Wound complications are one of the major sources of illness following orthopaedic procedures like knee and hip surgery. They can prolong a patient's stay in hospital or lead to re-admission. There is also a link between superficial wound infection and deep infection.
Orthopaedic surgeons use both metallic staples and nylon sutures to close wounds. Staples are regarded as quicker and easier than sutures, but some have suggested that staples are more likely to cause infection and may also be more expensive.
The optimal method of skin closure still remains unclear, so researchers at Norfolk and Norwich University Hospital analysed the results of six trials that compared the use of staples to sutures following orthopaedic procedures in adults.
The trials involved 683 wounds; 322 patients underwent suture closure and 351 staple closure. Overall, the risk of developing a superficial wound infection was over three times greater after staple closure than suture closure.
For hip surgery only, the risk of developing a wound infection was four times greater after staple closure than suture closure. There was no significant difference between sutures and staples in the development of inflammation, discharge, dehiscence (re-opening of a previously closed wound), necrosis and allergic reaction.
The authors point out that the quality of evidence was generally poor and they call for high quality, well designed trials to confirm their findings. However, based on the current evidence, they suggest that patients and doctors should think more carefully about the use of staples for wound closure after hip and knee surgery.
These results fit with evidence from other specialties, says Consultant Orthopaedic Surgeon, Bijayendra Singh, in an accompanying editorial. He points out that the most consistent benefit of staples is more rapid skin closure, yet the time saved is rarely more than two to three minutes. The saving may also be reduced by the increased costs of removing the staples (compared with absorbable stitches) and reduced even further by the costs of treating the increased number of infections.
Contacts:
Research: Toby Smith, Research Physiotherapist in Orthopaedics, Honorary Lecturer, Norfolk and Norwich University Hospital, Norwich, UK
Email: toby.smith@nnuh.nhs.uk Editorial: Bijayendra Singh, Consultant Orthopaedic Surgeon, Medway Foundation NHS Trust, Gillingham, UK
Email: bisortho@doctors.org.uk

Monday, March 23, 2009

AIM: End-of-life discussions drive down treatment costs, improve quality of life

Moral of the story: If you have a terminal illness discuss end-of-life decisions with your physician. You will be thankful in many ways as you will be on the same page as your doctor and painful, intensive treatments may be forgone for more comfortable arrangements.

AIM: End-of-life discussions drive down treatment costs
Daily Briefing - The Advisory Board Company
03/11/2009

Terminally ill patients who discussed end-of-life (EOL) care with their physicians had significantly lower health care costs and were more likely to have a better quality of life (QOL) in their final week of life compared with patients who did not have these conversations, according to a study published this week in the Archives of Internal Medicine (AIM). For the study, researchers from the Boston-based Dana-Farber Cancer Institute and colleagues followed a cohort of 627 patients with advanced cancer who were recruited for the longitudinal, multi-institutional Coping With Cancer Study between September 2002 and December 2007. At baseline—on average, six months before death—188 of 603 participants reported they had EOL discussions with their physicians. According to the findings, patients who had these discussions were more likely than their counterparts to acknowledge that they were terminally ill and report a desire to avoid dying in an ICU; patients who had EOL discussions were also less likely to prefer that their physicians take aggressive measures to extend life for a few days. As a result, the cost of care in the final week of life for patients who had discussed EOL goals with physicians averaged 35.7% lower (at an average of $1,876) than the cost of care for patients who did not have an EOL dialogue with their physicians, whose care during their final weeks of life averaged $2,917, according to aggregate costs of care determined using data from the 2004 Nationwide Inpatient Sample.

Additionally, higher costs of treatment in the final week of life were not associated with better outcomes; rather, high-cost patients experienced a worse quality of death, as reported by their caregivers. Noting that 30% of annual Medicare expenditures are attributed to the 5% of beneficiaries who die, and that about one-third of the expenditures in the last year of life are spent in the last month—mostly on life-sustaining care—the study’s authors suggest that EOL discussions between patients and providers may be an effective approach to curtailing medical care expenditures while improving patients’ quality of life and death. Specifically, the authors assert that if the “national proportion of individuals reporting EOL discussions” with health care providers increased to 50%, the cost difference between EOL and non-EOL patients could top $76 million nationally, based on the total number of U.S. cancer deaths annually. To that end, the authors support the adoption of strategies to “promote increased communication,” including direct reimbursement for EOL discussions, improved physician education regarding EOL communication, and expansion of hospital palliative care programs. Additionally, the authors suggest that oncologists and palliative care physicians co-manage care of patients with late-stage cancer.

STUDY FINDS END-OF-LIFE COSTS HIGHER AMONG BLACK, HISPANIC PATIENTS
In another study published in AIM, researchers from the Boston University School of Medicine and colleagues analyzed records of of more than 158,000 Medicare beneficiaries who died in 2001, finding that black and Hispanic patients have substantially higher EOL costs than white patients. Specifically, the mean cost of care for white patients averaged $20,166 across the last six months of life, compared with $26,704 for black patients and $31,702 for Hispanic patients. Although the study did not examine the direct cause of treatment cost disparities, the researchers attributed nearly 85% of the higher costs for non-white patients to greater use of ICU care and intensive procedures. According to the CMO of the American Cancer Society, higher utilization of life-extending procedures among minority patients may stem in part from the fact that minority populations are less likely to receive preventive care and establish long-term relationships with physicians (Zhang et al., AIM, 3/9 [subscription required]; Hanchate et al., AIM, 3/9 [subscription required]; Tanner, Associated Press/Los Angeles Times, 3/9; Stern, Reuters, 3/9; Smith, MedPage Today, 3/9).

Wednesday, March 18, 2009

Religious Belief Linked to Desire for Aggressive Treatment in Terminal Patients

Moral of the story: Religious individuals live a little longer but incur a greater cost, both in terms of quality of life in the final days and the number of greenbacks the use trying to get those last extra few days. Should taxpayers be spending so much money on such aggressive care?

Religious Belief Linked to Desire for Aggressive Treatment in Terminal Patients

Published: March 17, 2009 - NYTimes

Terminally ill cancer patients who drew comfort from religion were far more likely to seek aggressive, life-prolonging care in the week before they died than were less religious patients and far more likely to want doctors to do everything possible to keep them alive, a study has found.

The patients who were devout were three times as likely as less religious ones to be put on a mechanical ventilator to maintain breathing during the last week of life, and they were less likely to do any advance care planning, like signing a do-not-resuscitate order, preparing a living will or creating a health care proxy, the analysis found.

The study is to be published Wednesday in The Journal of the American Medical Association.

“People think that spiritual patients are more likely to say their lives are in God’s hands — ’Let what happens happen’ — but in fact we know they want more aggressive care,” said Holly G. Prigerson, the study’s senior author and director of the Center for Psychosocial Oncology and Palliative Care Research at the Dana-Farber Cancer Institute in Boston.

“To religious people, life is sacred and sanctified,” Dr. Prigerson said, “and there’s a sense they feel it’s their duty and obligation to stay alive as long as possible.”

Aggressive life-prolonging care comes at a cost, however, in terms of both dollars and human suffering. Medicare, the government’s health plan for the elderly, spends about one-third of its budget on people who are in the last year of life, and much of that on patients at the very end of life.

Aggressive end-of-life care can lead to a more painful process of dying, researchers have found, and greater shock and grief for the family members left behind.

The new study used both a questionnaire and interviews to assess the level of reliance on religious faith for comfort among 345 patients with advanced cancer. The patients, most of them belonging to Christian denominations, were followed until they died, about four months on average.

A vast majority of patients, religious or not, did not want heroic measures taken. Still, 11.3 percent of the most religious patients received mechanical ventilation during the last week of life, compared with only 3.6 percent of the least religious.

The most religious patients were also more likely than less religious ones to be resuscitated in the last week of life and to be treated in an intensive-care unit as they died, although those differences may have been due to chance.

“Doctors don’t always acknowledge, and I’m pretty sure patients are telling us, that God is really important in their lives,” said Dr. Gerard Silvestri, a cancer specialist at the Medical University of South Carolina in Charleston, S.C., who has studied end-of-life decision making.

A study by Dr. Silvestri in 2003 found that while cancer patients listed their oncologist’s recommendation as the most influential factor affecting their decisions about medical care, their faith in God was the second-most-influential factor, ranking higher than the recommendations of their family doctors, their spouses and children, and even information about whether treatment would cure the disease.

Tuesday, March 3, 2009

HealthGrades releases annual list of ‘America’s 50 Best Hospitals’

02/25/2009

HealthGrades yesterday released its annual list of “America’s 50 Best Hospitals,” which includes facilities that have ranked among the top 5% of the nation’s hospitals on clinical outcomes measures for at least the past six years across 26 common procedures and conditions. To create the list, researchers from the independent health care ratings organization reviewed more than 110 million hospitalization records that all non-federal U.S. hospitals—nearly 5,000 in total—submitted to CMS between fiscal years 1999 and 2007. After risk-adjusting the data to account for differences in patient populations among hospitals, HealthGrades compared facilities’ mortality and complication rates across the selected procedures and diagnoses, including spinal fusion, coronary bypass surgery and interventional procedures, myocardial infarction, heart failure, pneumonia, sepsis, and stroke, among others. To qualify for inclusion in the analysis, hospitals had to meet minimum thresholds for patient volumes, quality ratings, and the range of services provided. In releasing its 11th annual list—which includes 30 hospitals concentrated in just the four states of California, Florida, Ohio, and Pennsylvania—HealthGrades said that the top 50 hospitals had achieved mortality and complication rates that were approximately 27% and 8% lower, respectively, than those at all other U.S. hospitals. Examining the 2009 list, the Washington Post notes the omission of “several hospitals…that appear on most lists of the nation’s best,” adding that variation in different organizations’ ranking methodologies ultimately results “in wide variance from one list to the next.” Acknowledging that the exclusion of certain academic medical centers from HealthGrades’ top 50 “always calls into question the validity of this sort of list,” the company’s chief medical officer emphasizes that the HealthGrades list uses “a window based purely on outcomes” for 26 procedures and conditions, adding that many major medical centers’ reputations reflect their expertise across a broad range of specialties, including conditions and procedures beyond the scope of HealthGrades’ analysis (Halsey III, Washington Post, 2/25 [registration required]; HealthGrades release, 2/24). To view the complete “America’s 50 Best Hospitals” list, please visit the HealthGrades website at www.healthgrades.com.

Thursday, January 22, 2009

The Joint Commission to Include Patient Satisfaction Data on Quality Check™

Moral of the story: Health care is becoming more transparent, even if slowly. Check out the link below to check out the survey results for your area.


January 20, 2009
The Joint Commission to Include Patient Satisfaction Data on Quality Check™
Web site provides new information to help patients make decisions
Media Contact: Ken PowersMedia Relations Manager630-792-5175kpowers@jointcommission.org
(OAKBROOK TERRACE, Ill. – January 20, 2009) People seeking information about how patients perceive the care they received at a particular hospital can now find this information on The Joint Commission’s Quality Check™ Web site, http://www.qualitycheck.org/.
The Hospital Consumer Assessment of Health Providers and Systems (HCAHPS) data from the Centers for Medicare & Medicaid Services’ (CMS) Hospital Compare Web site is posted on Quality Check™ beginning this month. This information will be updated quarterly.
HCAHPS information comes from patient ratings of communication with doctors, communication with nurses, responsiveness of hospital staff, cleanliness and quietness of the hospital, pain management, communication about medications, and discharge information. In addition to information about patient satisfaction, Quality Check™ also includes data from CMS on 30-day mortality rates for heart attack, heart failure and pneumonia.
Thousands of people use Quality Check™ each month to find information about the more than 15,000 accredited health care organizations that have earned The Joint Commission “Gold Seal of Approval.” Quality Check™ provides details about an organization’s accreditation status, efforts to prevent medical mistakes by complying with National Patient Safety Goals, and comparison information about how hospitals comply with National Quality Improvement Goals such as giving heart attack patients aspirin within a specified timeframe.